Model Number M00517470 |
Device Problems
Break (1069); Activation, Positioning or Separation Problem (2906); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/22/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.Block h6: imdrf device code a15 captures the reportable event of stent partially deployed.
|
|
Event Description
|
It was reported to boston scientific corporation that an agile esophageal tts fuly covered stent was to be implanted in the esophagus to treat a malignant stricture during an esophagogastroduodenoscopy (egd) with stent placement procedure performed on (b)(6) 2024.During the procedure, the sheath broke during attempted deployment.The stent was removed from the patient partially deployed and another agile esophageal stent was used to complete the procedure.There were no patient complications as a result of this event.
|
|
Manufacturer Narrative
|
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.Block h6: imdrf device code a15 captures the reportable event of stent partially deployed.Block h10: an agile esophageal stent and delivery system were received for analysis.Visual examination of the returned device found the stent partially deployed, the outer sheath detached and the inner sheath and stainless steel kinked.No other problems were noted to the stent and delivery system.The reported events of stent partially deployed and sheath break can be confirmed.Taking all available information into consideration, the investigation concluded that the reported events and the observed damages were likely due to factors encountered during the procedure.It may be that lesion characteristics, handling of the device and the technique used by the physician (force applied), limited the performance of the device and contributed to the reported events and observed damages.Therefore, a review and analysis of the all the available information indicated that the most probable cause is adverse event related to procedure.
|
|
Event Description
|
It was reported to boston scientific corporation that an agile esophageal tts fuly covered stent was to be implanted in the esophagus to treat a malignant stricture during an esophagogastroduodenoscopy (egd) with stent placement procedure performed on (b)(6) 2024.During the procedure, the sheath broke during attempted deployment.The stent was removed from the patient partially deployed and another agile esophageal stent was used to complete the procedure.There were no patient complications as a result of this event.
|
|
Search Alerts/Recalls
|